Sponsor Pipeline

Michael Hopp Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 4
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT04413201 AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib… Non-squamous NSCLC Active, Not Recruiting
Phase 2
NCT04602533 Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease… Small Cell Lung Cancer Limited Stage Active, Not Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Small Cell Lung Cancer (1) Lung Cancer (1)
Get alerts when Michael Hopp's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free